Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354210 · ClinicalTrials.gov registry record · NA
Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01354210 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 110 participants.
The verdict
NCT01354210, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to test SMS (short message service) text messaging technology to improve medication adherence among youth living with HIV (YLH). The proposed study is a randomized controlled trial of the effect of text message reminders on ART (anti-retroviral therapy) adherence among non-adherent YLH. Daily text message reminders will be sent to patients randomized to the intervention group according to their medication schedule, for 6 months. The investigators will enroll non-adherent YLH, ages 16-29. Half of the sample, randomized to the intervention, will receive daily SMS text message medication reminders and half will be randomized to the control condition and receive standard of care (SOC) only. For the controlled trial, adherence levels and viral load will be collected at baseline, 3-month and 6-month follow-up. In addition, at the end of the initial 6-month enrollment period, participants in the control condition will cross-over to the SMS intervention and participants in the intervention condition will cease to receive the SMS intervention. Adherence and viral load data will be collected from each group at 9- and 12-month follow-up points. The investigators hypothesize that youth in the intervention condition will demonstrate a clinically meaningful increase in adherence at 3 and 6 months post-baseline, from approximately 70% to 90% adherence to ART.
Interventions
- BEHAVIORAL SMS Text Message Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01354210
The ClinicalTrials.gov registry entry for NCT01354210 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SMS Text Message Reminder is the first listed.
NCT01354210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01354210 about?
NCT01354210 is a clinical study titled "Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth". The purpose of the proposed study is to test SMS (short message service) text messaging technology to improve medication adherence among youth living with HIV (YLH). The proposed study is a randomized controlled trial of the effect of text message reminders on ART (anti-retroviral therapy) adherence...
What is the current status of trial NCT01354210?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2010-10. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01354210?
The interventions under investigation include: SMS Text Message Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT01354210?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.